The global hospital discharges for carcinoma in situ present significant variability across countries. As of 2023, Germany, with 34.22 thousand discharges, led the field, reflecting a slight year-on-year increase of 0.2%. South Korea followed with 29.07 thousand, showing the highest growth of 7.54%. Conversely, France and the UK recorded declines of 2.82% and 2.14%, respectively. Smaller markets like Slovenia and Iceland had negligible discharges, with Iceland showing notable growth of 3.83%, albeit from a low base. Five-year CAGR analysis highlights stable or negative trends, cautioning over expanding early detection consistent systems.
Looking ahead, technological advancements in early diagnosis and treatment, alongside healthcare policies in preventive measures, are poised to impact discharge frequencies. Countries with rising health expenditures may see increased discharges due to improved reporting and diagnostic capabilities. Monitoring healthcare investments and public health campaigns promoting early cancer screenings will be essential for understanding future variances in hospital discharges across nations.
Top countries in Hospital Discharges for Carcinoma in Situ by Country
| # | 10 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 34,220 | 2023 | +0.81% | +0.2% | View data |
| 2 | 2 South Korea | 29,070 | 2023 | +6.48% | +7.54% | View data |
| 3 | 3 Australia | 12,510 | 2023 | +2.34% | +1.83% | View data |
| 4 | 4 France | 11,490 | 2023 | -2.92% | -2.82% | View data |
| 5 | 5 Italy | 7,500 | 2023 | -0.39% | -1.21% | View data |
| 6 | 6 United Kingdom | 6,120 | 2023 | -1.92% | -2.14% | View data |
| 7 | 7 Switzerland | 2,700 | 2023 | +0.78% | -1.95% | View data |
| 8 | 8 Israel | 1,220 | 2023 | +4.53% | +1.36% | View data |
| 9 | 9 Sweden | 751 | 2023 | +0.81% | +0.16% | View data |
| 10 | 10 Bulgaria | 690 | 2021 | View data |
